Alteplase, a “clot-buster” medication used to treat ischemic stroke, acute myocardial infarctions, and acute pulmonary ...

Nonurban patients with suspected LVO who receive direct transportation to a thrombectomy-capable center have better functional outcomes.

Giving the clot-busting medication alteplase at the site of a blocked brain artery after blood clot removal may increase the number of patients who fully recover, according to preliminary ...

Delivering intra-arterial alteplase after successful mechanical thrombectomy improved functional recovery in patients with larg ...

Pulmonary embolism (PE) remains a major cause of cardiovascular morbidity and mortality worldwide. It occurs when thrombotic material—most often ...

New research presented today at the Society of NeuroInterventional Surgery's (SNIS) 19 th Annual Meeting shows that thrombectomy, a minimally invasive procedure typically reserved for treating a ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window PHOENIX -- ...

In patients who've had a large core stroke, the benefits of thrombectomy can continue to increase out to 1-year follow-up, new results from the SELECT2 trial showed. Other new data from the trial show ...

Each moment we are given holds possibility. Yet, every 40 seconds a person suffers from a stroke, which can take away that promise of possibility. Millions of Americans and their families are affected ...

The life-saving treatment can prevent avoidable death and long-term disability ...